These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease]. Leroy JL J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522 [No Abstract] [Full Text] [Related]
13. The prevention of hyaline membrane disease (HMD) in the preterm fetal lamb through the static inflation of the lungs: the conditioning of the fetal lungs. Kolobow T; Solca M; Presenti A; Buckhold D; Pierce JD Trans Am Soc Artif Intern Organs; 1980; 26():567-72. PubMed ID: 6910328 [TBL] [Abstract][Full Text] [Related]
14. Hyaline membrane disease of the newborn, revisited. Macomber PB J Maine Med Assoc; 1975 Jul; 66(7):187-90. PubMed ID: 1173595 [No Abstract] [Full Text] [Related]
15. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Liggins GC; Howie RN Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295 [No Abstract] [Full Text] [Related]
16. Effect of corticosteroids and fetomaternal disorders on the L:S ratio. Morrison JC; Schneider JM; Whybrew WD; Bucovaz ET Obstet Gynecol; 1980 Nov; 56(5):583-90. PubMed ID: 6893624 [TBL] [Abstract][Full Text] [Related]